Apogee Therapeutics Inc [NASDAQ: APGE] surged by $1.07 during the normal trading session on while it closed the day at $33.11.
Apogee Therapeutics Inc stock has also gained 10.59% of its value over the past 7 days. However, APGE stock has declined by -9.78% in the 3 months of the year. Over the past six months meanwhile, it has lost -39.67% and lost -26.91% year-on date.
The market cap for APGE stock reached $1.97 billion, with 45.99 million shares outstanding and 37.14 million shares in the current float. Compared to the average trading volume of 689.19K shares, APGE reached a trading volume of 347815 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Apogee Therapeutics Inc [APGE]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for APGE shares is $93.88 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on APGE stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Citigroup have made an estimate for Apogee Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 13, 2025. While these analysts kept the previous recommendation, Canaccord Genuity raised their target price to Buy. The new note on the price target was released on November 25, 2024, representing the official price target for Apogee Therapeutics Inc stock. Previously, the target price had yet another raise to $80, while BofA Securities analysts kept a Buy rating on APGE stock.
The Average True Range (ATR) for Apogee Therapeutics Inc is set at 3.01 The Price to Book ratio for the last quarter was 2.75, with the Price to Cash per share for the same quarter was set at 8.75.
APGE stock trade performance evaluation
Apogee Therapeutics Inc [APGE] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 10.59. With this latest performance, APGE shares dropped by -18.13% in over the last four-week period, additionally sinking by -39.67% over the last 6 months – not to mention a drop of -34.64% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for APGE stock in for the last two-week period is set at 45.63, with the RSI for the last a single of trading hit 46.94, and the three-weeks RSI is set at 45.30 for Apogee Therapeutics Inc [APGE]. The present Moving Average for the last 50 days of trading for this stock 35.67, while it was recorded at 32.62 for the last single week of trading, and 45.19 for the last 200 days.
Apogee Therapeutics Inc [APGE]: An insightful look at the core fundamentals
Apogee Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 18.55 and a Current Ratio set at 18.55.
Earnings per share (EPS) analysis for Apogee Therapeutics Inc [APGE] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for APGE. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Apogee Therapeutics Inc go to -22.96%.
Apogee Therapeutics Inc [APGE]: Institutional Ownership
There are presently around $129.95%, or 146.60%% of APGE stock, in the hands of institutional investors. The top three institutional holders of APGE stocks are: VR ADVISER, LLC with ownership of 8.49 million shares, which is approximately 15.0284%. FMR LLC, holding 7.51 million shares of the stock with an approximate value of $$295.36 million in APGE stocks shares; and FMR LLC, currently with $$139.57 million in APGE stock with ownership which is approximately 6.2761%.
